Bank of Nova Scotia’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-445,625
| Closed | -$44.3M | – | 1012 |
|
|
2019
Q3 | $44.3M | Sell |
445,625
-268,529
| -38% | -$25.5M | 0.13% | 150 |
|
|
2019
Q2 | $65.5M | Buy |
714,154
+17,398
| +2% | +$1.65M | 0.27% | 80 |
|
|
2019
Q1 | $65.7M | Buy |
696,756
+376,236
| +117% | +$32.9M | 0.26% | 88 |
|
|
2018
Q4 | $20.5M | Buy |
320,520
+85,330
| +36% | +$6.3M | 0.1% | 180 |
|
|
2018
Q3 | $21M | Buy |
235,190
+144,429
| +159% | +$12.8M | 0.09% | 197 |
|
|
2018
Q2 | $7.21M | Sell |
90,761
-157,159
| -63% | -$13M | 0.04% | 299 |
|
|
2018
Q1 | $22.1M | Sell |
247,920
-27,618
| -10% | -$2.65M | 0.11% | 172 |
|
|
2017
Q4 | $28.8M | Buy |
275,538
+133,205
| +94% | +$15M | 0.13% | 161 |
|
|
2017
Q3 | $20.8M | Sell |
142,333
-49,018
| -26% | -$6.68M | 0.12% | 164 |
|
|
2017
Q2 | $24.9M | Sell |
191,351
-669
| -0.3% | -$82K | 0.13% | 148 |
|
|
2017
Q1 | $23.9M | Buy |
192,020
+148,375
| +340% | +$17.8M | 0.1% | 172 |
|
|
2016
Q4 | $5.05M | Buy |
43,645
+27,907
| +177% | +$3.11M | 0.03% | 254 |
|
|
2016
Q3 | $1.65M | Buy |
15,738
+130
| +0.8% | +$14.1K | 0.01% | 336 |
|
|
2016
Q2 | $1.54M | Buy |
15,608
+860
| +6% | +$89K | 0.01% | 318 |
|
|
2016
Q1 | $1.48M | Sell |
14,748
-175,920
| -92% | -$18.1M | 0.01% | 322 |
|
|
2015
Q4 | $22.8M | Buy |
190,668
+175,940
| +1,195% | +$20.4M | 0.12% | 108 |
|
|
2015
Q3 | $1.59M | Buy |
14,728
+400
| +3% | +$49.6K | 0.01% | 284 |
|
|
2015
Q2 | $1.66M | Buy |
14,328
+615
| +4% | +$70.3K | 0.01% | 241 |
|
|
2015
Q1 | $1.58M | Buy |
13,713
+131
| +1% | +$15.7K | 0.01% | 243 |
|
|
2014
Q4 | $1.52M | Buy |
13,582
+428
| +3% | +$45.1K | 0.01% | 245 |
|
|
2014
Q3 | $1.25M | Buy |
13,154
+596
| +5% | +$53.8K | 0.01% | 265 |
|
|
2014
Q2 | $1.08M | Sell |
12,558
-94,432
| -88% | -$7.18M | ﹤0.01% | 278 |
|
|
2014
Q1 | $7.47M | Sell |
106,990
-50,430
| -32% | -$3.99M | 0.03% | 173 |
|
|
2013
Q4 | $13.3M | Buy |
157,420
+146,686
| +1,367% | +$11.6M | 0.06% | 147 |
|
|
2013
Q3 | $826K | Sell |
10,734
-202,314
| -95% | -$14.2M | ﹤0.01% | 285 |
|
|
2013
Q2 | $12.5M | Buy |
+213,048
| New | +$12.8M | 0.06% | 125 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Bank of Nova Scotia's CELG Position: Q4 2019 in Review
Bank of Nova Scotia sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 445,625 shares — an estimated $44.3M sold.
Bank of Nova Scotia first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $65.7M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bank of Nova Scotia reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bank of Nova Scotia sold 445,625 Celgene Corp shares in Q4 2019, an estimated $44.3M.
- Bank of Nova Scotia first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Bank of Nova Scotia's Celgene Corp position peaked at $65.7M in Q1 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bank of Nova Scotia's 13F filing for Q4 2019, filed 13 Feb 2020.